Access Is Power: Opioid Use Disorder and Reproductive Health

Fact Sheet

Access Is Power: Opioid Use Disorder and Reproductive Health

Generic Fact Sheet image

As the incidence of opioid use disorder in pregnancy has increased, so too has the number of infants born with neonatal abstinence syndrome (NAS). Women with opioid use disorder are at increased risk for unplanned pregnancy. Given this increased risk, one primary prevention strategy for reducing the incidence of NAS and utilization of the foster system that states and communities should consider is to address the reproductive health needs of individuals with substance use disorder (SUD). For women not in recovery, many barriers including cost, fear of mistreatment, and lack of transportation, contribute to a high rate of unplanned pregnancy. Even for those in recovery, barriers remain. This brief highlights several state and local initiatives to increase knowledge about, and access to, reproductive health services for women with SUD.

July 2018

Related Resources

Fact Sheet
Currently, 23 states (including DC) have enacted policies to allow pharmacists to prescribe and dispense self-administered hormonal methods.
Fact Sheet
An infographic on the state of pharmacist prescribing in the United States.
Fact Sheet
In 2019, Title X-supported centers provided contraceptive care to 4,411 women in South Dakota.
Fact Sheet
Power to Decide have synthesized, analyzed, and visualized state-level telehealth policies pre-COVID and during COVID, with a focus on those impact birth control.